FREDUN PHARMACEUTICALS Financial Statement Analysis
|
||
The Revenues of FREDUN PHARMACEUTICALS have increased by 26.75% YoY .
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 39.47 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
FREDUN PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539730]
Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹348 Cr | ₹275 Cr | ₹224 Cr | ₹134 Cr | ₹113 Cr |
Expenses | ₹310 Cr | ₹247 Cr | ₹211 Cr | ₹125 Cr | ₹104 Cr |
Operating Profit (Excl OI) | ₹38 Cr | ₹28 Cr | ₹14 Cr | ₹9.35 Cr | ₹8.33 Cr |
Other Income | ₹0.92 Cr | ₹1.82 Cr | ₹1.63 Cr | ₹1.40 Cr | ₹0.52 Cr |
Interest | ₹14 Cr | ₹9.28 Cr | ₹4.78 Cr | ₹4.37 Cr | ₹4.48 Cr |
Depreciation | ₹3.80 Cr | ₹2.81 Cr | ₹2.16 Cr | ₹2.00 Cr | ₹1.88 Cr |
Profit Before Tax | ₹21 Cr | ₹18 Cr | ₹8.60 Cr | ₹3.21 Cr | ₹2.50 Cr |
Profit After Tax | ₹16 Cr | ₹11 Cr | ₹6.34 Cr | ₹2.02 Cr | ₹1.90 Cr |
Earnings Per Share (Rs) | ₹33.25 | ₹23.84 | ₹14.29 | ₹5.05 | ₹4.77 |
PAT Margin (%) | 4.49 | 3.93 | 2.82 | 1.50 | 1.69 |
ROE(%) | 15.03 | 13.86 | 11.42 | 4.77 | 4.74 |
ROCE(%) | 17.13 | 17.64 | 13.15 | 9.53 | 10.36 |
Total Debt/Equity(x) | 0.88 | 0.98 | 0.78 | 0.92 | 0.84 |
Key Financials |
||
Market Cap | : | ₹ 584.8 Cr |
Revenue (TTM) | : | ₹ 497.3 Cr |
Net Profit(TTM) | : | ₹ 23.4 Cr |
EPS (TTM) | : | ₹ 49.9 |
P/E (TTM) | : | 24.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
FREDUN PHARMACEUTICALS | 2.7% | 17.5% | 57.5% |
SUN PHARMACEUTICAL INDUSTRIES | 2% | 1.4% | -13% |
DIVIS LABORATORIES | 1.3% | 0.3% | 10.4% |
CIPLA | 0.3% | 1.9% | -6.1% |
TORRENT PHARMACEUTICALS | 0% | -2.3% | 2.6% |
DR REDDYS LABORATORIES | 0.5% | 6.2% | -1.4% |
MANKIND PHARMA | 2.3% | 5.9% | 4.6% |
ZYDUS LIFESCIENCES | 0.3% | 6% | -7.2% |
LUPIN | 0.2% | 4% | -9.8% |
FREDUN PHARMACEUTICALS Revenues
[BOM: 539730]
Y-o-Y | 26.75 % |
5 Yr CAGR | 32.55 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹348 Cr | 26.75 | |
Mar2023 | ₹275 Cr | 22.37 | |
Mar2022 | ₹224 Cr | 67.64 | |
Mar2021 | ₹134 Cr | 18.73 | |
Mar2020 | ₹113 Cr | - |
FREDUN PHARMACEUTICALS Operating Profit
[BOM: 539730]
Y-o-Y | 36.74 % |
5 Yr CAGR | 46.12 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹38 Cr | 36.74 | |
Mar2023 | ₹28 Cr | 99.68 | |
Mar2022 | ₹14 Cr | 48.83 | |
Mar2021 | ₹9.35 Cr | 12.20 | |
Mar2020 | ₹8.33 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 7.91 % |
5 Yr CAGR | 10.23 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 10.91% | 7.91 | |
Mar2023 | 10.11% | 63.06 | |
Mar2022 | 6.2% | -11.17 | |
Mar2021 | 6.98% | -5.55 | |
Mar2020 | 7.39% | - |
FREDUN PHARMACEUTICALS Profit After Tax
[BOM: 539730]
Y-o-Y | 44.56 % |
5 Yr CAGR | 69.29 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹16 Cr | 44.56 | |
Mar2023 | ₹11 Cr | 70.59 | |
Mar2022 | ₹6.34 Cr | 214.39 | |
Mar2021 | ₹2.02 Cr | 5.94 | |
Mar2020 | ₹1.90 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 14.25 % |
5 Yr CAGR | 27.67 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 4.49 % | 14.25 | |
Mar2023 | 3.93 % | 39.36 | |
Mar2022 | 2.82 % | 88.00 | |
Mar2021 | 1.5 % | -11.24 | |
Mar2020 | 1.69 % | - |
FREDUN PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539730]
Y-o-Y | 39.47 % |
5 Yr CAGR | 62.49 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹33 | 39.47 | |
Mar2023 | ₹24 | 66.83 | |
Mar2022 | ₹14 | 182.97 | |
Mar2021 | ₹5.05 | 5.87 | |
Mar2020 | ₹4.77 | - |
FREDUN PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539730]
Y-o-Y | -2.89 % |
5 Yr CAGR | 13.40 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 17.13% | -2.89 | |
Mar2023 | 17.64% | 34.14 | |
Mar2022 | 13.15% | 37.99 | |
Mar2021 | 9.53% | -8.01 | |
Mar2020 | 10.36% | - |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Current Share Price | : | ₹1,244.3 |
Current MarketCap | : | ₹ 584.8 Cr |
Updated EOD on | : | Sep 18,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | 2.7% |
17.5% |
57.5% |
SENSEX | 1.8% |
2.1% |
0.2% |
FREDUN PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about FREDUN PHARMACEUTICALS Financials
How the annual revenues of FREDUN PHARMACEUTICALS have changed ?
The Revenues of FREDUN PHARMACEUTICALS have increased by 26.75% YoY .
How the Earnings per Share (EPS) of FREDUN PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of FREDUN PHARMACEUTICALS has increased by 39.47 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs